Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Expanded access open-label bardoxolone methyl for pulmonary arterial hypertension
MOH_2017-05-09_000396Phase 3Not yet recruiting
- Sponsor
- Reata Pharmaceuticals
- Start
- Apr 2017
- Modality
- Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of bardoxolone methyl in pulmonary arterial hypertension (PAH), sponsored by Reata Pharmaceuticals. Planned start Apr 2017; status: not yet recruiting.
02
Drugs
bardoxolone methyl
03
Conditions
pulmonary arterial hypertension (PAH)
Beyond the preview
Go deeper on MOH_2017-05-09_000396.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2017-05-09_000396.